2013
DOI: 10.1016/j.ijcard.2011.11.081
|View full text |Cite
|
Sign up to set email alerts
|

Suppression of erythropoiesis in patients with chronic heart failure and anaemia of unknown origin: evidence of an immune basis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
16
2

Year Published

2013
2013
2016
2016

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 24 publications
(18 citation statements)
references
References 41 publications
0
16
2
Order By: Relevance
“…Inflammatory biomarkers, as indicated by previous evidence, can provide important prognostic information for HF [43]. On the other hand, it is widely accepted that inflammation inhibits erythrocyte maturation and accelerates the migration of reticulocytes into the peripheral circulation, thereby increasing RDW [44][46]. Indeed, the positive relationships between RDW and inflammatory indices have also been documented [30], [47], [48].…”
Section: Discussionmentioning
confidence: 85%
“…Inflammatory biomarkers, as indicated by previous evidence, can provide important prognostic information for HF [43]. On the other hand, it is widely accepted that inflammation inhibits erythrocyte maturation and accelerates the migration of reticulocytes into the peripheral circulation, thereby increasing RDW [44][46]. Indeed, the positive relationships between RDW and inflammatory indices have also been documented [30], [47], [48].…”
Section: Discussionmentioning
confidence: 85%
“…Finally, ALAS2 is known to be positively regulated by erythropoietin (EPO) in erythroblasts (33) and EPO levels are often elevated in HF patients due to the underlying anemia (34). EPO receptor was previously shown to be expressed in the human heart (35), suggesting that cardiomyocytes may respond to EPO signaling.…”
Section: Resultsmentioning
confidence: 99%
“…The significance of these findings in the context of failing hearts remains to be determined. Despite elevated EPO levels, HF patients were found to be resistant to EPO signaling in promoting hematopoiesis (34), but it remains unknown whether the sensitivity of cardiomyocytes to EPO stimulation is also altered.…”
Section: Discussionmentioning
confidence: 99%
“…Thus, a possible explanation for the associations between AF or RBBB and the increased levels of hemoglobin is that increased blood levels of hemoglobin may reflect increased erythropoiesis which results from subclinical tissue hypoperfusion caused by AF or RBBB in an apparently normal heart. In contrast, patients with chronic heart failure are frequently anemic despite elevated endogenous EPO levels due to EPO resistance which results from impaired EPO-induced signal transduction (15) and a suppression of erythropoiesis by heart failure-related inflammation (16). EPO induces positive inotropic and lusitropic effects in the murine and human myocardium (17).…”
Section: Discussionmentioning
confidence: 99%